Vimarsana
Biggest News Aggregation in the World

Page 2 - Evercode Whole Transcriptome News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Evercode Whole Transcriptome. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Evercode Whole Transcriptome Today - Breaking & Trending Today

Parse Biosciences Launches CRISPR Detect - Vimarsana News

Parse Biosciences Launches CRISPR Detect

Parse Biosciences a leading provider of accessible and scalable single cell sequencing solutions announced today the launch of CRISPR Detect enabling single cell pooled CRISPR screens at unprecedented scale.

Parse Biosciences Expands Global Access to Israel - Vimarsana News

Parse Biosciences Expands Global Access to Israel

Parse Biosciences a leading provider of accessible and scalable single cell sequencing solutions today announced an agreement with Israelbased Ornat Biochemicals and Laboratory Equipment to extend Parses reach in the Middle East.

10X Genomics Sues Parse Biosciences, Inc. alleging Infringement of Single-Cell Genomics Patents - Vimarsana News

10X Genomics Sues Parse Biosciences, Inc. alleging Infringement of Single-Cell Genomics Patents

On Wednesday, 10X Genomics, Inc. filed a complaint in the District of Delaware against Parse Biosciences, Inc. and the Board of Trustees of Leland

Parse Biosciences raises $41.5M Series B round to scale single-cell sequencing products and expand product portfolio - Vimarsana News

Parse Biosciences raises $41.5M Series B round to scale single-cell sequencing products and expand product portfolio

Parse Biosciences, a company dedicated to providing scalable single-cell sequencing solutions, today announced $41.5M in Series B funding co-led by Marshall ...

Parse Biosciences Raises $41.5M Series B Round to Scale Single-Cell Sequencing Products and Expand Product Portfolio - Vimarsana News

Parse Biosciences Raises $41.5M Series B Round to Scale Single-Cell Sequencing Products and Expand Product Portfolio

Company to commercialize and create single-cell multi-omics products Parse Biosciences, a company dedicated to providing scalable single-cell sequencing solutions, today announced $41.5M in Series